Alternatives to Cellino

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Oncology real-world evidence built from point-of-care patient data, with AI-powered analysis layered on top.

All-in-human foundation models that read a routine blood draw to predict brain activity, therapy response, and side effects in neurology.

Causal AI drug discovery that pairs 20+ petabytes of cellular data with human genetics to find real disease targets

Recursion runs AI drug discovery as a lab-in-the-loop engine — automated cellular imaging at scale feeding generative chemistry and a clinical pipeline.

Cellbyte is the AI workspace where pharma Pricing & Market Access teams get source-linked HTA and pricing answers in minutes.

Nanograb designs peptide-LNP targeting systems with biophysics-informed AI so genetic medicines reach a chosen cell type instead of the

Owkin's K Pro is an autonomous AI scientist for drug discovery and clinical trial decisions, built on multimodal patient data

Clinical-stage techbio company pairing automated wet labs with AI models to discover and develop drugs.

Silico is Goodfire's mechanistic interpretability agent for understanding, debugging, and steering the internals of your AI models.

Clinical-stage biotech designing highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

Iktos pairs generative AI for small-molecule design with AI retrosynthesis and robotic lab automation.

Renamed: Deep 6 AI was acquired by Tempus AI in March 2025 and its trial matching folded into Tempus.

Physics-based molecular simulation with AI for drug discovery and materials design.

Benchling unifies ELN, LIMS, and AI agents for biotech R&D in one cloud platform.

FDA-cleared AI for cancer pathology on H&E slides, plus the Virchow and PRISM foundation models licensed to biopharma and researchers.

Quibim turns MRI, CT and PET scans into cleared, quantitative imaging biomarkers for prostate, brain, liver, breast and lung.

Tempus pairs tumor DNA/RNA sequencing with AI precision oncology analytics to surface treatment and trial matches

AI protein engineering platform that designs optimized variant plates and learns from every wet-lab round.

BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.

PathAI's AISight Dx brings FDA-cleared digital pathology and AI biomarker algorithms to labs and biopharma trials.

Enterprise scientific intelligence platform whose Luma Agent plans, runs and documents R&D data analysis under human approval

Recursion's AI drug discovery platform pairing 2M weekly wet-lab experiments with a 50+ PB proprietary dataset, now incorporating Exscientia.

Automated cloud lab for protein validation — binding, expression and thermostability assays with data back in as little as 3 days

WhiteLab Genomics' ALFRED platform predicts and optimizes molecular constructs for gene and RNA therapies before synthesis

SciSpace BioMed Agent runs multi-omics, variant prioritization, and drug repurposing analysis from plain-language biomedical prompts.

Novaflow is an AI data analyst that runs scRNA-seq, spatial, and multi-omics pipelines from raw data to publication-ready figures and

AI-CRISPR target discovery platform pairing AlgenCRISPR gene modulation with the AlgenBrain foundation model for causal immunology and

AI patient identification for clinical trials: HealthKey scans your EHR daily and emails your team trial-eligible patients.